1. 2023
  2. Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis

    Kroes, J. A., Alfonso-Cristancho, R., Bansal, A. T., Berret, E., Bieksiene, K., Bourdin, A., Brussino, L., Canhoto, D., Cardini, C., Celik, G., Csoma, Z., Dahlén, B., Damadoglu, E., Eger, K., Gauquelin, L., Gemicioglu, B., Goksel, O., Graff, S., Heffler, E., Hofstee, H. B., & 24 othersHowarth, P., Jakes, R. W., Jaun, F., Kalinauskaite-Zukauske, V., Kopač, P., Kwon, N., Loureiro, C. C., García, V. L., Masoli, M., Rezelj, M. P., de Llano, L. P. R., Popović-Grle, S., Ramos-Barbón, D., Sousa, A. S., Samitas, K., Schleich, F., Sirena, C., Skrgat, S., Zervas, E., Zichnalis, G., Bel, E. H., Sont, J. K., Hashimoto, S. & Brinke, A. T., 1 Mar 2023, In: ERJ open research. 9, 2, 00745-2022.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. A novel assay for improved detection of sputum periostin in patients with asthma

    BIOAIR consortium, 1 Feb 2023, In: PLoS ONE. 18, 2 February, e0281356.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. 2022
  5. Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study

    PONENTE Study Group, 1 Dec 2022, In: European respiratory journal. 60, 6

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma

    Korn, S., Howarth, P., Smith, S. G., Price, R. G., Yancey, S. W., Prazma, C. M. & Bel, E. H., Dec 2022, In: Respiratory research. 23, 1, p. 45 45.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  7. Migration and allergic diseases: Findings from a population-based study in adults in Amsterdam, the Netherlands

    Amoah, A. S., Prins, M., Bel, E. H. D., Fokkens, W. J., Zwinderman, A. H., Yazdanbakhsh, M., Maitland-van der Zee, A. H. & van Ree, R., Dec 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 12, p. 3667-3670 4 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  8. Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma

    the RAPSODI team., 1 Nov 2022, In: European respiratory journal. 60, 5, 2102983.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

    Frix, A-N., Heaney, L. G., Dahlén, B., Mihaltan, F., Sergejeva, S., Popović-Grle, S., Sedlak, V., Lehtimäki, L., Bourdin, A., Korn, S., Zervas, E., Csoma, Z., Lúðvíksdóttir, D., Butler, M., Canonica, G. W., Grisle, I., Bieksiene, K., ten Brinke, A., Kuna, P., Loureiro, C. C., & 11 othersNenasheva, N. M., Lazic, Z., Škrgat, S., Ramos-Barbon, D., Leuppi, J., Gemicioglu, B., Bossios, A., Porsbjerg, C. M., Bel, E. H., Djukanovic, R. & Louis, R., 1 Oct 2022, In: ERJ open research. 8, 4, 00273-2022.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers

    Hashimoto, S., Kroes, J. A., Eger, K. A., Mau Asam, P. F., Hofstee, H. B., Bendien, S. A., Braunstahl, G. J., Broeders, M. E. A. C., Imming, L. M., Langeveld, B., Maitland-van der Zee, A. H., Oud, K. T. M., Patberg, K. W., Smeenk, F. W. J. M., Romme, E. A. P. M., van Bezouw, M. J., van de Ven, M. J., van Veen, A., van Velzen, E., van Veen, I. H. P. A. A., & 5 othersWeersink, E. J. M., RAPSODI team, ten Brinke, A., Sont, J. K. & Bel, E. H., Aug 2022, In: Journal of Allergy and Clinical Immunology: In Practice. 10, 8, p. 2099-2108.e6

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Reply to “Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma”

    Eger, K., Kroes, J. A., ten Brinke, A. & Bel, E. H., 1 Jul 2022, In: Journal of Allergy and Clinical Immunology: In Practice. 10, 7, p. 1936 1 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  12. The effect of the COVID-19 pandemic on severe asthma care in Europe: Will care change for good?

    Eger, K., Paroczai, D., Bacon, A., Schleich, F., Sergejeva, S., Bourdin, A., Vachier, I., Zervas, E., Katsoulis, K., Papapetrou, D., Kostikas, K., Csoma, Z., Heffler, E., Canonica, G. W., Grisle, I., Bieksiene, K., Palacionyte, J., Brinke, A. T., Hashimoto, S., Smeenk, F. W. J. M., & 46 othersBraunstahl, G-J., van der Sar, S., Mihălţan, F., Nenasheva, N., Peredelskaya, M., Zvezdin, B., Čekerevac, I., Hromiš, S., Ćupurdija, V., Lazic, Z., Milenkovic, B., Dimic-Janjic, S., Yasinska, V., Dahlén, B., Bossios, A., Lazarinis, N., Aronsson, D., Egesten, A., Munir, A. K. M., Ahlbeck, L., Janson, C., Škrgat, S., Edelbaher, N., Leuppi, J., Jaun, F., Rüdiger, J., Pavlov, N., Gianella, P., Fischer, R., Charbonnier, F., Chaudhuri, R., Smith, S. J., Doe, S., Fawdon, M., Masoli, M., Heaney, L., Haitchi, H. M., Kurukulaaratchy, R., Fulton, O., Frankemölle, B., Gibson, T., Needham, K., Howarth, P., Djukanovic, R., Bel, E. & Hyland, M., 1 Apr 2022, In: ERJ open research. 8, 2, 00065-2022.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...26 Next

ID: 40688